top of page

Our Team

IMMvention is powered by its experienced team with deep expertise in drug discovery and development across multiple therapeutic areas

Don Haut
Don Haut, PhD
Executive Chair
McKinsey & Company
MDCO Company
Aspect
AskBio
Anil Goyal
Anil Goyal, PhD
CEO and Co-founder
Ribo
Millennium Takeda
Serenex
Jess Sorrentino_edited_edited.jpg
Jessica  Sorrentino, PhD
CSO/Head of R&D
Ribo
Istari images.png
G1 logo.jpeg
matthew gallovic
Matt Gallovic, PhD
Sr. Director of R&D
Baxter
UNC Chapel Hill
Montana 2.webp
Montana Wagner-Gillespie
Program Director
Tiamet.jpeg
biomilq.png
Wakemed logo.png
Roheeth Pavana.jpeg
Roheeth Pavana, PhD
Director, Medicinal Chemistry
Ribo
Raybow.png
newlink_edited.jpg
gsk.jpeg
IMMvention-Background.png

Board of Directors

EXECUTIVE CHAIR
Don Haut, PhD, Independent
CEO and Director
Anil Goyal, PhD, IMMvention
DIRECTOR and CO-FOUNDER
Jenny Ting, PhD, UNC, Chapel Hill
DIRECTOR
Matt Cohen, PhD, Osage University Partners
DIRECTOR
Ben Scruggs, PhD, Hatteras Venture Partners
DIRECTOR
Colin Freund, PhD, Delin Ventures
OBSERVER
Caroline Haegeman, PhD, Delin Ventures
orangeGlow.jpg

Let's collaborate

Interested in partnering with us? Reach out to start the conversation
Immvention mark

© 2025 IMMvention Therapeutix

bottom of page